Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some critical information is ...

Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...

A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Company’s presentation will provide updates on SkinJect® Phase 2b Pivotal Study in patients with Gorlin Syndrome and Teverelix® Groundbreaking PRECISION-E2 Phase 2a Endometriosis Study leveraging the ...

Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer Novel immunotherapy technology demonstrating ...

Traditional SSVEP stimuli are essentially high‑contrast brightness modulations that strongly activate the occipital visual cortex, but they are ...

Advances in soft materials are reshaping the design of next-generation devices, particularly where flexibility, adaptability, ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...